Inhaled Nitric Oxide in Severe Obesity
NCT: NCT06675435 · NOT_YET_RECRUITING
Brief Summary
The goal of this clinical trial is to learn about the effects of inhaled nitric oxide on oxygenation and lung perfusion in participants with severe obesity who have acute hypoxemic respiratory failure and are on mechanical ventilation The main questions it aims to answer are: 1. In acute hypoxemic respiratory failure, what are the effects of inhaled nitric oxide on oxygenation in participants with severe obesity compared to participants with normal body weight. 2. In acute hypoxemic respiratory failure, what are the effects of inhaled nitric oxide on lung perfusion and heart function in participants with severe obesity compared to participants with normal body weight. 3. In acute hypoxemic respiratory failure, does severe obesity impact nitric oxide signaling pathways? Participants with acute hypoxemic respiratory failure will be exposed to inhaled nitric oxide (20 ppm) while being clinically monitored.
Frequently Asked Questions
What is Inhaled Nitric Oxide in Severe Obesity?
Inhaled Nitric Oxide in Severe Obesity is a clinical trial registered under NCT06675435. Current status: NOT_YET_RECRUITING.
What is the status of NCT06675435?
The current status of NCT06675435 (Inhaled Nitric Oxide in Severe Obesity) is: NOT_YET_RECRUITING.
When did Inhaled Nitric Oxide in Severe Obesity start?
Inhaled Nitric Oxide in Severe Obesity started on 2026-10.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.